Literature DB >> 23768306

Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib.

Amy Iarrobino1, Jane L Messina, Ragini Kudchadkar, Vernon K Sondak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23768306     DOI： 10.1016/j.jaad.2013.01.023

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  10 in total

1.  Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma.

Authors:  Audris Chiang; Caroline Z Tan; François Kuonen; Luqman M Hodgkinson; Felicia Chiang; Raymond J Cho; Andrew P South; Jean Y Tang; Anne Lynn S Chang; Kerri E Rieger; Anthony E Oro; Kavita Y Sarin
Journal:  J Invest Dermatol       Date:  2019-06-15       Impact factor: 8.551

Review 2.  Hedgehog Signaling: From Basic Biology to Cancer Therapy.

Authors:  Fujia Wu; Yu Zhang; Bo Sun; Andrew P McMahon; Yu Wang
Journal:  Cell Chem Biol       Date:  2017-03-09       Impact factor: 8.116

3.  RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.

Authors:  Xuesong Zhao; Tatyana Ponomaryov; Kimberly J Ornell; Pengcheng Zhou; Sukriti K Dabral; Ekaterina Pak; Wei Li; Scott X Atwood; Ramon J Whitson; Anne Lynn S Chang; Jiang Li; Anthony E Oro; Jennifer A Chan; Joseph F Kelleher; Rosalind A Segal
Journal:  Cancer Res       Date:  2015-06-30       Impact factor: 12.701

4.  Efficacy of Vismodegib (Erivedge) for Basal Cell Carcinoma Involving the Orbit and Periocular Area.

Authors:  Hakan Demirci; Francis Worden; Christine C Nelson; Victor M Elner; Alon Kahana
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 Nov-Dec       Impact factor: 1.746

Review 5.  Genetic and environmental factors underlying keratinocyte carcinoma risk.

Authors:  Hélène Choquet; Sepideh Ashrafzadeh; Yuhree Kim; Maryam M Asgari; Eric Jorgenson
Journal:  JCI Insight       Date:  2020-05-21

Review 6.  Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer.

Authors:  Hao Xie; Brooke D Paradise; Wen Wee Ma; Martin E Fernandez-Zapico
Journal:  Cells       Date:  2019-04-29       Impact factor: 6.600

7.  Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma.

Authors:  Raymond Zhao; Bo Wang; Lori Lowe; Andrzej Dlugosz; Christopher K Bichakjian
Journal:  JAAD Case Rep       Date:  2022-08-10

8.  Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face.

Authors:  Alec M Block; Fiori Alite; Aidnag Z Diaz; Richard W Borrowdale; Joseph I Clark; Mehee Choi
Journal:  Case Rep Oncol Med       Date:  2015-10-04

Review 9.  Advanced basal cell carcinoma, the hedgehog pathway, and treatment options - role of smoothened inhibitors.

Authors:  Leslie A Fecher; William H Sharfman
Journal:  Biologics       Date:  2015-11-06

Review 10.  Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.

Authors:  Roberto Corchado-Cobos; Natalia García-Sancha; Rogelio González-Sarmiento; Jesús Pérez-Losada; Javier Cañueto
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.